Sangamo Therapeutics, Inc. (SGMOQ)
OTCMKTS · Delayed Price · Currency is USD
0.1449
+0.0038 (2.69%)
At close: Sep 18, 2026
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of $60.03 million as of September 18, 2026. Its market cap has decreased by -61.19% in one year.
Market Cap
60.03M
Enterprise Value
51.78M
Revenue
34.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
ChartMarket Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from 92.36M to 60.03M, a decrease of -35.01%. That is a compound annual growth rate of -1.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 60.03M | -57.52% |
| Dec 31, 2025 | 141.33M | -33.59% |
| Dec 31, 2024 | 212.82M | 120.88% |
| Dec 29, 2023 | 96.35M | -81.28% |
| Dec 30, 2022 | 514.58M | -52.90% |
| Dec 31, 2021 | 1.09B | -50.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 121.58M |
| HST Global | 91.93M |
| NDT Pharmaceuticals | 79.81M |
| Nuo Therapeutics | 60.06M |
| Arch Biopartners | 44.48M |
| BetterLife Pharma | 42.17M |
| ProText Mobility | 30.77M |
| Cell Source | 29.90M |